Li Li Huang

Xinhua Biopharmaceutical (Guangzhou) Co., Ltd. is a Chinese company that specializes in revolutionizing protein drug discovery and development. The company is based in Guangzhou, China. The company integrates the most up-to-date AI technologies, such as bioinformatics, machine learning, deep learning algorithms, graph neural network, deep generative model, and traditional drug development processes. The company was founded in 2019 by Oliver Zhang, Lu Quan Wang. Lu Quan Wang has been the CEO since 2019.

Xinhua Biopharmaceutical (Guangzhou) Co., Ltd. is a Chinese company that specializes in revolutionizing protein drug discovery and development. The company is based in Guangzhou, China. The company integrates the most up-to-date AI technologies, such as bioinformatics, machine learning, deep learning algorithms, graph neural network, deep generative model, and traditional drug development processes. The company was founded in 2019 by Oliver Zhang, Lu Quan Wang. Lu Quan Wang has been the CEO since 2019.

Xinhua Biopharmaceutical (Guangzhou) Co., Ltd. is a Chinese company that specializes in revolutionizing protein drug discovery and development. The company is based in Guangzhou, China. The company integrates the most up-to-date AI technologies, such as bioinformatics, machine learning, deep learning algorithms, graph neural network, deep generative model, and traditional drug development processes. The company was founded in 2019 by Oliver Zhang, Lu Quan Wang. Lu Quan Wang has been the CEO since 2019.

Xinhua Biopharmaceutical (Guangzhou) Co., Ltd. is a Chinese company that specializes in revolutionizing protein drug discovery and development. The company is based in Guangzhou, China. The company integrates the most up-to-date AI technologies, such as bioinformatics, machine learning, deep learning algorithms, graph neural network, deep generative model, and traditional drug development processes. The company was founded in 2019 by Oliver Zhang, Lu Quan Wang. Lu Quan Wang has been the CEO since 2019.

Xinhua Biopharmaceutical (Guangzhou) Co., Ltd. is a Chinese company that specializes in revolutionizing protein drug discovery and development. The company is based in Guangzhou, China. The company integrates the most up-to-date AI technologies, such as bioinformatics, machine learning, deep learning algorithms, graph neural network, deep generative model, and traditional drug development processes. The company was founded in 2019 by Oliver Zhang, Lu Quan Wang. Lu Quan Wang has been the CEO since 2019.